InterventionsHuman trialMice12 weeksRandomised trial

Effects of Wilac D001 (Weissella confusa WIKIM51) Supplementation on Metabolic Parameters and Central Adiposity in Overweight Adults: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial

Fig. 1. Flow chart showing the origin of the subjects included in this study, as well as the reasons for exclusion.
Open the figure at full size
Fig. 1. Flow chart showing the origin of the subjects included in this study, as well as the reasons for exclusion.Flow chart showing the origin of the subjects included in this study, as well as the reasons for exclusion.Park et al.

Journal of Microbiology and Biotechnology

The paper

Park S, Lee B, Sun H et al.

Journal of Microbiology and Biotechnology · 2 Sep 2026

doi.org/10.4014/jmb.2606.06054PubMed 42750456

More on GLP-1 and incretin signalling